Skip to main content

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Gemma Cuberas Borros

Gemma Cuberas Borros

Research technician
Molecular Imaging and Therapy
Read more
Rafael Simó Canonge

Rafael Simó Canonge

Head of group
Diabetes and Metabolism
Read more
Mar Xunclà  Lloret

Mar Xunclà Lloret

Predoctoral researcher
Genetics Medicine
Read more
Anna  Abuli  Vidal

Anna Abuli Vidal

Postdoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.